|
|
|
|
| Explore the evolving role of exosomes and extracellular vesicles (EVs) at the next Cell & Gene Live. Chief Editor Erin Harris moderates a discussion with Capricor’s Linda Marbán and Aegle’s Dr. Gloria Matthews on clinical and commercial advances, including applications in rare and cardiovascular diseases. Gain insights into the future of exosome-based therapies from leaders driving innovation across R&D, manufacturing, and commercialization. |
|
|
|
|
By Natalie Farris, Naltou Pharma CMC Consulting LLC | CMC experts (whether in-house or outsourced) fill a vital role during the transition from small-scale production to larger operations for maintaining quality, consistency, and compliance. | |
|
|
|
| Key Challenges In mRNA Manufacturing | Article | Novartis Contract Manufacturing | Manufacturing mRNA products is a complex and challenging process that requires careful consideration at each stage. Learn more about the challenges and intricacies involved. |
|
|
| Improving Transient Transfection AAV Production | Article | By Jacob Smith, Viralgen | By refining variables such as starting DNA, reagents, cell density, and media composition, organizations can improve rAAV process efficiency and scalability. |
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
